Processa Pharmaceuticals, Inc. (PCSA)
Nasdaq: PCSA · Pharmaceutical Preparations · Vero Beach, FL · filing with the SEC since 2011
Who runs Processa Pharmaceuticals, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Ng George K
Chief Executive Officer. First filing Aug 2023, latest Aug 11, 2026, 12 filings in all.
Officers reporting now
6
of 11 people with a filing in the last fifteen months
Directors reporting now
5
15 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ng George K | Chief Executive Officer | Aug 2023 | Aug 11, 2026 | none |
| Skibsted Russell | Chief Financial Officer | Jul 2024 | Jul 28, 2026 | none |
| Guy Wendy | Chief Administrative Officer | Oct 2020 | Jul 28, 2026 | none |
| Lin Patrick | Chief Business - Strategy Off | Oct 2020 | Jul 28, 2026 | none |
| Young David | Pres. Research & Development | Oct 2020 | Jul 1, 2026 | none |
| Bigora Sian | Chief Development Officer | Oct 2020 | May 19, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gujrathi Sheila | director | Jul 2026 | Jul 30, 2026 | none |
| Baluch Khoso | director | Jul 2022 | Jul 28, 2026 | none |
| Neal James R | director | Jul 2022 | Jul 28, 2026 | none |
| Pannu Geraldine | director | Oct 2020 | Jul 28, 2026 | none |
| Yorke Justin W | director | Oct 2020 | Jul 28, 2026 | none |
Earlier names on the record5, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.